Agenus: Better immunotherapies
Agenus focuses on antibody discovery and immuno-oncology with platforms like Retrocyte Display for rapid lead generation. It supports checkpoint and bispecific programs. Compared to Abalone Bio, Agenus centers on immune modulation via binding rather than GPCR functional activation at massive scale. Its display tech enables quick hits but without Abalone Bio's yeast-linked activity assays or proprietary datasets for AI-driven activator design on challenging targets.
Agenus develops immunotherapies that activate the immune system to recognize and eliminate cancer, with a focus on reducing reliance on chemotherapy, radiation, and surgery. Its lead program pairs botensilimab (BOT) and balstilimab (BAL) and has reported durable responses and meaningful survival in advanced checkpoint-refractory melanoma as well as activity in MSS colorectal cancer, Merkel cell carcinoma, and sarcoma. The company maintains a pipeline spanning the cancer immunity cycle and supports patient access and ongoing clinical trials.
Free

Culturally responsive mental health resources and therapist directory for Black women and girls.

NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Online therapy for teens and parents via text, phone, and video from licensed therapists.